XML 113 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

STOCKHOLDERS’ DEFICIT (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Jun. 30, 2024
Equity [Abstract] |  |
SCHEDULE OF WARRANT ACTIVITY | The following table summarizes warrant activity for the nine months ended March 31, 2025: SUMMARY OF WARRANT ACTIVITY
|  |  |  |  | Weighted |
|  | Number of |  |  | Average |
|  | Shares |  |  | Price Per Share |
Outstanding at June 30, 2024 |  |  | 250 |  |  | $ | 74,400 |
Granted |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Cancelled * |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Outstanding at March 31, 2025 |  |  | 250 | * |  | $ | 0.01 |
Exercisable at March 31, 2025 |  |  | 250 |  |  | $ | 0.01 |
Outstanding and Exercisable: |  |  |  |  |  |  |  |
Weighted average remaining contractual term |  |  | 1.26 |  |  |  |  |
Aggregate intrinsic value |  | $ | - |  |  |  |  |
* |  | On March 3, 2025, the Company cancelled all the existing warrants (0.0002 Series A warrants, 0.0003 Series B warrants, and 0.0008 Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above).
| The following table summarizes common stock warrant activity for the years ended June 30, 2024 and 2023: SCHEDULE OF WARRANT ACTIVITY
|  |  |  |  | Weighted |
|  | Number of |  |  | Average |
|  | Warrants |  |  | Price Per Share |
Outstanding at June 30, 2022 |  |  | 0.002 |  |  | $ | 12,016,200,000 |
Issued |  |  | 0.06 |  |  |  | 600,000 |
Exercised |  |  | (0.0002 | ) |  |  | 3,124,860,000 |
Forfeited |  |  | (0.00002 | ) |  |  | 120,000,000,000 |
Expired |  |  | - |  |  |  | - |
Outstanding at June 30, 2023 |  |  | 0.06 |  |  | $ | 326,400,000 |
Issued |  |  | 250 |  |  |  | 74,400 |
Exercised |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Outstanding at June 30, 2024 |  |  | 250 | * |  | $ | 74,400 |
Exercisable at June 30, 2024 |  |  | 250 |  |  | $ | 74,400 |
Outstanding and Exercisable: |  |  |  |  |  |  |  |
Weighted average remaining contractual term |  |  | 2.01 |  |  |  |  |
Aggregate intrinsic value |  | $ | - |  |  |  |  |
* | The total warrants of 250 above which are exercisable into common stock consisted of the following:
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY |  | A summary of the Company’s stock option activity during the years ended June 30, 2024 and 2023 is presented below: SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY
|  |  |  |  | Weighted |
|  | Number of |  |  | Average |
|  | Options |  |  | Price Per Share |
Outstanding at June 30, 2022 |  |  | 0.000001 |  |  | $ | 271,980,000,000 |
Issued |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Outstanding at June 30, 2023 |  |  | 0.000001 |  |  | $ | 271,980,000,000 |
Issued |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Outstanding at June 30, 2024 |  |  | 0.000001 |  |  | $ | 271,980,000,000 |
Exercisable at June 30, 2024 |  |  | 0.000001 |  |  | $ | 271,980,000,000 |
Outstanding and Exercisable: |  |  |  |  |  |  |  |
Weighted average remaining contractual term |  |  | 4.87 |  |  |  |  |
Weighted average fair value of options granted during the period |  | $ | - |  |  |  |  |
Aggregate intrinsic value |  | $ | - |  |  |  |  |
SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE |  | SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE
|  | Number of Warrants |  |  | Exercisable |
Series A warrants |  |  | 0.0002 |  |  |  | 0.0002 |
Series B warrants |  |  | 0.0003 |  |  |  | 0.0003 |
Series C warrants |  |  | 0.001 |  |  |  | 0.0008 |
Common stock warrants with no class designation |  |  | 250 |  |  |  | 250 |
Total |  |  | 250 |  |  |  | 250 |

X
- Definition Schedule of Warrants Outstanding and Exercisable [Table Text Block] + References No definition available. + Details
Name: | PPCB_ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock
Namespace Prefix: | PPCB_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration